HN2002000050A - PHARMACEUTICALLY ACTIVE COMPOUNDS - Google Patents
PHARMACEUTICALLY ACTIVE COMPOUNDSInfo
- Publication number
- HN2002000050A HN2002000050A HN2002000050A HN2002000050A HN2002000050A HN 2002000050 A HN2002000050 A HN 2002000050A HN 2002000050 A HN2002000050 A HN 2002000050A HN 2002000050 A HN2002000050 A HN 2002000050A HN 2002000050 A HN2002000050 A HN 2002000050A
- Authority
- HN
- Honduras
- Prior art keywords
- active compounds
- pharmaceutically active
- etil
- useful
- phosphodyphate
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 abstract 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical class C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 abstract 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 abstract 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 abstract 1
- 101100189582 Dictyostelium discoideum pdeD gene Proteins 0.000 abstract 1
- 101150098694 PDE5A gene Proteins 0.000 abstract 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 1
- 102100029175 cGMP-specific 3',5'-cyclic phosphodiesterase Human genes 0.000 abstract 1
- 229940029575 guanosine Drugs 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS FARMACEUTICAMENTE UTILES Y EN PARTICULAR, A 5 (2-BUTOXI - 3 - (1 - HIDROXIETIL) - 3 - PIRIDINIL - 3 - ETIL - 2 - (1 - ETIL - - AZETIDINIL) - 2, 6 - DIHIDRO - 7H - PIRAZOLO (4, 3 - D) PIRIMIDIN 7 - ONA, QUE SSON UTILES EN LA INHIBICION DE LAS FOSFODIESTERASAS DE GUANOSINA 3', 5' - MONOFOSFATO CICLICO DE TIPO 5 (GMPc PDE5).THIS INVENTION REFERS TO PHARMACEUTICALLY USEFUL AND PARTICULAR COMPOUNDS, A 5 (2-BUTOXI - 3 - (1 - HYDROXYETHYL) - 3 - PIRIDINIL - 3 - ETIL - 2 - (1 - ETIL - - AZETIDINIL) - 2, 6 - DIHIDRO - 7H - PIRAZOLO (4, 3 - D) PIRIMIDIN 7 - ONA, WHICH ARE USEFUL IN THE INHIBITION OF GUANOSINE 3 ', 5' PHOSPHODIESTERASES - TYPE 5 CYCLIC PHOSPHODYPHATE (GMPc PDE5).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0105893.2A GB0105893D0 (en) | 2001-03-09 | 2001-03-09 | Pharmaceutically active compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HN2002000050A true HN2002000050A (en) | 2002-09-13 |
Family
ID=9910362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HN2002000050A HN2002000050A (en) | 2001-03-09 | 2002-03-08 | PHARMACEUTICALLY ACTIVE COMPOUNDS |
Country Status (8)
| Country | Link |
|---|---|
| AP (1) | AP2002002462A0 (en) |
| GB (1) | GB0105893D0 (en) |
| GT (1) | GT200200044A (en) |
| HN (1) | HN2002000050A (en) |
| PA (1) | PA8541101A1 (en) |
| PE (1) | PE20021153A1 (en) |
| TN (1) | TNSN02023A1 (en) |
| WO (1) | WO2002072586A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
| US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
| EP2196201A3 (en) | 2002-12-13 | 2010-12-08 | Warner-Lambert Company LLC | Combination of an alpha-2-delta ligand with a pdev inhibitor or a muscarinic antagonist to treat lower urinary tract symptoms |
| BRPI0411985A (en) * | 2003-07-16 | 2006-08-29 | Pfizer | treatment of sexual dysfunction |
| ES2646326T3 (en) | 2005-08-03 | 2017-12-13 | Sprout Pharmaceuticals, Inc. | Use of flibanserin in the treatment of obesity |
| CA2626134C (en) | 2005-10-29 | 2013-12-24 | Boehringer Ingelheim International Gmbh | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
| ATE456369T1 (en) | 2006-06-30 | 2010-02-15 | Boehringer Ingelheim Int | FLIBANSERIN FOR THE TREATMENT OF URINARY INCONTINENCE AND ASSOCIATED DISEASES |
| AU2007286288A1 (en) | 2006-08-14 | 2008-02-21 | Boehringer Ingelheim International Gmbh | Formulations of flibanserin and method for manufacturing the same |
| BRPI0716436B8 (en) | 2006-08-25 | 2021-05-25 | Boehringer Ingelheim Int | controlled release system and method for manufacturing it |
| CL2008002693A1 (en) | 2007-09-12 | 2009-10-16 | Boehringer Ingelheim Int | Use of flibanserin for the treatment of selected vasomotor symptoms of hot flashes, night sweats, mood swings, and irritability |
| CA2686480A1 (en) | 2008-12-15 | 2010-06-15 | Boehringer Ingelheim International Gmbh | New salts |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL343794A1 (en) * | 1998-04-20 | 2001-09-10 | Pfizer | Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| GB9823101D0 (en) * | 1998-10-23 | 1998-12-16 | Pfizer Ltd | Pharmaceutically active compounds |
| AU7547900A (en) * | 1999-10-11 | 2001-04-23 | Pfizer Inc. | 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-yl)- dihydropyrazolo(4,3-d)pyrimidin-7-ones as phosphodiesterase inhibitors |
| CO5271697A1 (en) * | 2000-01-12 | 2003-04-30 | Pfizer Prod Inc | COMPOSITIONS AND PROCEDURES FOR THE TREATMENT OF AFFECTIONS THAT RESPOND TO AN INCREASE OF TESTOSTERONE |
-
2001
- 2001-03-09 GB GBGB0105893.2A patent/GB0105893D0/en not_active Ceased
-
2002
- 2002-02-27 WO PCT/IB2002/000622 patent/WO2002072586A1/en not_active Ceased
- 2002-03-06 GT GT200200044A patent/GT200200044A/en unknown
- 2002-03-07 AP APAP/P/2002/002462A patent/AP2002002462A0/en unknown
- 2002-03-07 PE PE2002000183A patent/PE20021153A1/en not_active Application Discontinuation
- 2002-03-08 PA PA20028541101A patent/PA8541101A1/en unknown
- 2002-03-08 TN TNTNSN02023A patent/TNSN02023A1/en unknown
- 2002-03-08 HN HN2002000050A patent/HN2002000050A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB0105893D0 (en) | 2001-04-25 |
| GT200200044A (en) | 2002-12-02 |
| PE20021153A1 (en) | 2002-12-17 |
| PA8541101A1 (en) | 2003-11-12 |
| WO2002072586A1 (en) | 2002-09-19 |
| AP2002002462A0 (en) | 2002-06-30 |
| TNSN02023A1 (en) | 2005-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HN2004000538A (en) | "PIRIDO [2,3-d] PYRIMIDINE-2,4-DIAMINES AS-INHIBITORS OF PDE 2" | |
| DK1265889T3 (en) | Drugs for viral diseases | |
| DE60215157D1 (en) | USES OF ANTIVIRAL NUCLEOSIDE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HEPATITIS C INFECTIONS | |
| EP1371406A4 (en) | ALVEOLAR STRUCTURAL BODY | |
| BG108268A (en) | Pyrazolopyrimidines as therapeutic agents | |
| ITRM20000483A0 (en) | STRUCTURED CLOTHING FOR THE PROTECTION OF THE MOTORCYCLIST. | |
| HN2001000224A (en) | IMIDAZOL COMPOUNDS CONDENSED WITH ARILO OR HETEROARILO AS ANTI - INFLAMMATORY AND ANALGESIC AGENTS. | |
| EP1401840A4 (en) | NOVEL THIOPHENO 2,3-D | PYRIMIDINES 4-AMINO-5,6-SUBSTITUTES | |
| AR028106A1 (en) | FORMULATIONS OF POTASSIUM GLYPHOSATE | |
| BG108269A (en) | Pyrazolopyrimidines as therapeutic agents | |
| ATE388713T1 (en) | 4-AMINO-6-PHENYL-PYRROLO(2,3-D)PYRIMIDINE DERIVATIVES | |
| EP1495141A4 (en) | HIV THERAPEUTIC | |
| MXPA03000803A (en) | VAGINAL SUPPLY OF BISPHOSPHONATES. | |
| ATE517891T1 (en) | HIV-INHIBITING PYRIMIDINE DERIVATIVES | |
| BR9902086A (en) | Pharmaceutical formulations. | |
| BR0108485A (en) | Azaindole antiviral derivatives | |
| HN2001000027A (en) | PURINA DERIVATIVES | |
| HUP0401190A3 (en) | Treatment of nail infections using no generating compositions | |
| CY1105390T1 (en) | THERAPEUTIC MANAGEMENT OF PULMONARY HYPERTENSION | |
| BR0208154A (en) | Cyclically guanosine 3 ', 5'-monophosphate phosphodiesterase inhibitors | |
| PT1513514E (en) | TOPICAL FORMULATIONS OF HYDROXIMATAIRESINOL | |
| HN2002000050A (en) | PHARMACEUTICALLY ACTIVE COMPOUNDS | |
| ITTO20010120A0 (en) | PROCEDURE FOR THE MANUFACTURE OF A HOLLOW BODY CONSTITUTING A BICYCLE COMPONENT, IN PARTICULAR FOR THE MANUFACTURE OF THE BOX | |
| BRPI0313080A2 (en) | formulations with reduced aerosol generation | |
| ITPD20040244A1 (en) | PASSIVE MOBILIZATION TABLE OF THE ANKLE ARTICULATION. |